Anew Labs raises $290M in first external round post-ByteDance spinout, valuing the AI drug-discovery company at $1.5B post-money.
Amount Raised
$290 Million
Round Type
Venture
Investors
Description
Anew Labs completed its first external financing round on September 16, 2026, raising $290 million after spinning out of ByteDance. The round values the AI drug-discovery company at approximately $1.5 billion post-money, while ByteDance retains about 56% ownership. Investors include HSG, IDG Capital, Hillhouse Investment, 5Y Capital, Gaorong Ventures, Primavera Venture Partners, Boyu Capital, SBP Group, and the Shanghai Future Industries Fund. The financing demonstrates outside capital participation while ByteDance maintains its controlling stake in the company.
Quick answer
Anew Labs raised $290 Million in a funding round, dated September 16, 2026. Investors: Hong Shan, 5Y Capital, IDG Capital, Shanghai Future Industries Fund, SBP Group, Boyu Capital, Primavera Venture Partners and Gaorong Ventures.
- How much did Anew Labs raise?
- Anew Labs raised $290 Million in a funding round on September 16, 2026.
- Who invested in Anew Labs?
- Hong Shan, 5Y Capital, IDG Capital, Shanghai Future Industries Fund, SBP Group, Boyu Capital, Primavera Venture Partners and Gaorong Ventures are named as investors in this round.
- What does Anew Labs do?
- Anew Labs is an AI-assisted drug-discovery company that spun out of ByteDance's AI-for-Science team in June 2026.
- Where is Anew Labs based and how big is it?
- Fundz records about 2 employees.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Anew Labs that raised within 45 days of this round, from Fundz verified event records.
- Pathos AI raised $237M (Series E) on October 23, 2026.
- Outer Bio raised $23M on August 26, 2026.
- VUSE XR raised $1.3M (Pre-Seed) on October 29, 2026.
- Albert raised an undisclosed amount on October 26, 2026.
- Empirical Machines raised $20M on October 17, 2026.
- Recursion Pharmaceuticals raised $200M (Post-IPO Equity) on October 15, 2026.
Who to call at Anew Labs, and when
A new round usually means Anew Labs is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Anew Labs raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Anew Labs, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Anew Labs. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Anew Labs raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Anew Labs raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.